Novel dual LSD1/HDAC6 inhibitor for the treatment of cancer.
Gajendran C, Tantry SJ, M NS, Mohammed Z, Dewang P, Hallur M, Nair S, Vaithilingam K, Nagayya B, Rajagopal S, Sivanandhan D.
Gajendran C, et al.
PLoS One. 2023 Jan 3;18(1):e0279063. doi: 10.1371/journal.pone.0279063. eCollection 2023.
PLoS One. 2023.
PMID: 36595522
Free PMC article.